DPA Comments to FDA re: International Drug Scheduling

The Drug Policy Alliance submitted this letter in response to the Food and Drug Administration’s (FDA) request for comments concerning the international scheduling of 16 drug substances, including cannabis. Cannabis does not meet the criteria for a Schedule I substance, as defined by the Controlled Substances Act of 1970, because it has several well-documented medical uses and minimal potential for abuse. For these reasons, DPA supports removing cannabis entirely from the Schedule of Controlled Substances.

Marijuana Legalization and Regulation